This is good news to hear...

phrannie51

...and short to read.

p

http://news.yahoo.com/merck-immunotherapy-appears-effective-head-neck-cancer-study-180653301--finance.html?soc_src=mediacontentsharebuttons

wmc

That is very good news for H&N

Wow, works three times better in reducing or shrinking tumors. That's HOPE

Noellesmom

whoo hoo!

That's the best thing I've read in a long time!  Long term survival - beautiful words.

Grandmax4

awesome

I watched this on the news, a lady had suffered from colon cancer for 6 years and Drs had about given up, her too, then they decided to try this method...she is cancer free and living a normal life...praise God

MrsBD

Thanks, Phrannie. That is

Thanks, Phrannie. That is very good news!  With every discovery we're closer to a cure.

KTeacher

Like button

And where is the like button when you need it?!  Hopeful.

wmc

KTeacher said:

Like button

And where is the like button when you need it?!  Hopeful.

I have one

Here you go   

joannaw81

wmc said:

I have one

Here you go   

thanks for posting this Phrannie

good news!

wmc

wmc said:

I have one

Here you go   

It's for the TEACHER

I should have done it in an apple...... It's for the Teacher,  always wanted to say that. Brings back memories of grade school.

corleone

Thanks for posting this link.

 

Pembrolizumab is a drug marketed by Merck that targets the programmed cell death 1 (PD-1) receptor. 

What I find even more fascinating and encouraging is the combination of ipilimumab (monoclonal antibody developed by Bristol-Myers Squibb that works to activate the immune system by targeting CTLA-4, a protein receptor that downregulates the immune system) and nivolumab (similar action to the one posted by you, is an anti-PD-1 monoclonal antibody developed by Bristol-Myers Squibb).

The combination of the 2 was possible because they are produced by the same manufacture. It’s for different indication, but I am pretty sure it will prove to be useful for H&N cancers.

See http://www.cnn.com/2015/06/01/health/immunotherapy-cancer-treatment-advance/index.html

 

Hondo

corleone said:

Thanks for posting this link.

 

Pembrolizumab is a drug marketed by Merck that targets the programmed cell death 1 (PD-1) receptor. 

What I find even more fascinating and encouraging is the combination of ipilimumab (monoclonal antibody developed by Bristol-Myers Squibb that works to activate the immune system by targeting CTLA-4, a protein receptor that downregulates the immune system) and nivolumab (similar action to the one posted by you, is an anti-PD-1 monoclonal antibody developed by Bristol-Myers Squibb).

The combination of the 2 was possible because they are produced by the same manufacture. It’s for different indication, but I am pretty sure it will prove to be useful for H&N cancers.

See http://www.cnn.com/2015/06/01/health/immunotherapy-cancer-treatment-advance/index.html

 

P

Thanks again that is great news just hope and pray I never need it.

 

Tim

Guzzle

Hondo said:

P

Thanks again that is great news just hope and pray I never need it.

 

Tim

NHS
U.K. NHS invested heavily in research. They are calling it a game changer.

donfoo

cures near...

I visited my medical oncologist a couple weeks ago and we had a long chat about cures. He is dead convinced cancer is caused by virus that go undetected by the immune system. Something triggers the sleeping virus and it spreads while the immune system does not fight it. He says the current research is discovering the true nature of the disease and these new targeted therapies is the way to the cure. He said they have already identified a few specific virus that cause specific types of cancer. Real cures are finally near.

debbiejeanne

wow, that is very

wow, that is very encouraging!  thx for sharing.

dj